Gangliosidoses

M. C. Patterson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The gangliosidoses are a family of lysosomal storage diseases caused by deficiencies of enzymes (or their activator protein partners) that catabolize glycosphingolipids known as gangliosides. The disorders are named according to the dominant species of accumulating ganglioside (i.e., GM1 or GM2). The most severe phenotypes present as rapidly progressive neurodegenerative disorders in infancy; cherry-red spots occur in both GM1 and GM2 gangliosidosis. Less profound enzyme deficiencies present later in life with less severe, fragmentary phenotypes that may mimic other diseases, such as spinocerebellar degenerations.

Original languageEnglish (US)
Title of host publicationEncyclopedia of the Neurological Sciences
PublisherElsevier Inc.
Pages400-401
Number of pages2
ISBN (Electronic)9780123851574
ISBN (Print)9780123851581
DOIs
StatePublished - Jan 1 2014

Fingerprint

Gangliosidoses
GM2 Gangliosidosis
G(M2) Ganglioside
GM1 Gangliosidosis
Spinocerebellar Degenerations
Lysosomal Storage Diseases
G(M1) Ganglioside
Phenotype
Glycosphingolipids
Gangliosides
Enzymes
Neurodegenerative Diseases
Proteins

Keywords

  • Activator protein
  • Cherry-red spot
  • Gangliosides
  • Gangliosidoses
  • GM1
  • GM2
  • GM3
  • Hexosaminidase
  • I'-Galactosidase
  • Lysosomal storage disease
  • Morquio B
  • Sandhoff
  • Tay-Sachs

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Patterson, M. C. (2014). Gangliosidoses. In Encyclopedia of the Neurological Sciences (pp. 400-401). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-385157-4.00097-X

Gangliosidoses. / Patterson, M. C.

Encyclopedia of the Neurological Sciences. Elsevier Inc., 2014. p. 400-401.

Research output: Chapter in Book/Report/Conference proceedingChapter

Patterson, MC 2014, Gangliosidoses. in Encyclopedia of the Neurological Sciences. Elsevier Inc., pp. 400-401. https://doi.org/10.1016/B978-0-12-385157-4.00097-X
Patterson MC. Gangliosidoses. In Encyclopedia of the Neurological Sciences. Elsevier Inc. 2014. p. 400-401 https://doi.org/10.1016/B978-0-12-385157-4.00097-X
Patterson, M. C. / Gangliosidoses. Encyclopedia of the Neurological Sciences. Elsevier Inc., 2014. pp. 400-401
@inbook{b02abffecd2f4eeb82ef8df1d61713a1,
title = "Gangliosidoses",
abstract = "The gangliosidoses are a family of lysosomal storage diseases caused by deficiencies of enzymes (or their activator protein partners) that catabolize glycosphingolipids known as gangliosides. The disorders are named according to the dominant species of accumulating ganglioside (i.e., GM1 or GM2). The most severe phenotypes present as rapidly progressive neurodegenerative disorders in infancy; cherry-red spots occur in both GM1 and GM2 gangliosidosis. Less profound enzyme deficiencies present later in life with less severe, fragmentary phenotypes that may mimic other diseases, such as spinocerebellar degenerations.",
keywords = "Activator protein, Cherry-red spot, Gangliosides, Gangliosidoses, GM1, GM2, GM3, Hexosaminidase, I'-Galactosidase, Lysosomal storage disease, Morquio B, Sandhoff, Tay-Sachs",
author = "Patterson, {M. C.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-385157-4.00097-X",
language = "English (US)",
isbn = "9780123851581",
pages = "400--401",
booktitle = "Encyclopedia of the Neurological Sciences",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Gangliosidoses

AU - Patterson, M. C.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The gangliosidoses are a family of lysosomal storage diseases caused by deficiencies of enzymes (or their activator protein partners) that catabolize glycosphingolipids known as gangliosides. The disorders are named according to the dominant species of accumulating ganglioside (i.e., GM1 or GM2). The most severe phenotypes present as rapidly progressive neurodegenerative disorders in infancy; cherry-red spots occur in both GM1 and GM2 gangliosidosis. Less profound enzyme deficiencies present later in life with less severe, fragmentary phenotypes that may mimic other diseases, such as spinocerebellar degenerations.

AB - The gangliosidoses are a family of lysosomal storage diseases caused by deficiencies of enzymes (or their activator protein partners) that catabolize glycosphingolipids known as gangliosides. The disorders are named according to the dominant species of accumulating ganglioside (i.e., GM1 or GM2). The most severe phenotypes present as rapidly progressive neurodegenerative disorders in infancy; cherry-red spots occur in both GM1 and GM2 gangliosidosis. Less profound enzyme deficiencies present later in life with less severe, fragmentary phenotypes that may mimic other diseases, such as spinocerebellar degenerations.

KW - Activator protein

KW - Cherry-red spot

KW - Gangliosides

KW - Gangliosidoses

KW - GM1

KW - GM2

KW - GM3

KW - Hexosaminidase

KW - I'-Galactosidase

KW - Lysosomal storage disease

KW - Morquio B

KW - Sandhoff

KW - Tay-Sachs

UR - http://www.scopus.com/inward/record.url?scp=85043273556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043273556&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-385157-4.00097-X

DO - 10.1016/B978-0-12-385157-4.00097-X

M3 - Chapter

AN - SCOPUS:85043273556

SN - 9780123851581

SP - 400

EP - 401

BT - Encyclopedia of the Neurological Sciences

PB - Elsevier Inc.

ER -